Singapore

BMI expects more drugmakers in South East Asia to get Good Manufacturing Practice (GMP) accreditation after a major trade agreement was signed. Upgrading facilities and processes... 2009-04-15

French firm Servier has launched Coralan (ivabradine) in Singapore for the treatment of angina. Because of the city state's affluence and the increasing burden of cardiovascular disease,... 2008-08-13

The National Healthcare Group (NHG) of hospitals in Singapore has contracted local real-time systems provider TCM-RFiD to help pharmacists, nurses and doctors keep track of pharmaceuticals... 2008-02-04

Driven by increasing global demand for medicines, the export of pharmaceuticals from Singapore increased dramatically in March 2007. The trade figures have been welcomed by the country's... 2007-04-18

BMI has reaffirmed its encouraging prospects for Singapore's biomedical sector after UK-based GlaxoSmithKline (GSK) announced that a clinical candidate will emerge from the Biopolis... 2007-03-13

With no national debt and the economy growing at 6.3% in 2006, according to BMI forecasts, Singapore is able to invest around US$25- US$30mn on average per year in stem cell research.... 2007-01-03

Singapore has completed the first phase of its Biomedical Science (BMS) initiative, and is keen to push on to phase II, which will have government investment of US$1.4bn. Under the... 2006-11-24